On September 23, Gelonghui reported that Yidu Technology (02158.HK) announced that its affiliate, Tianjin Happy Life Technology Co., Ltd., has won the bid for the Phase III clinical research project ...

On September 23, Gelonghui reported that Yidu Technology (02158.HK) announced that its affiliate, Tianjin Happy Life Technology Co., Ltd., has won the bid for the Phase III clinical study project of ...

Recombinant proteins are at the heart of modern biopharmaceutical innovation, enabling breakthroughs in drug discovery, vaccine development, and precision medicine” - By Transparency Market ...

Halozyme Therapeutics (HALO) is a $9 billion biotech focused on oncology and boasting sales and profit growth of 29% and 46%, respectively, while trading a sub-11x forward P/E. HALO is focused on the ...

The global flow cytometry market is expected to witness a CAGR of ~9% during the forecast period. High incidence and ...

Novavax, Inc.’s outlook improves with a Sanofi partnership and upgraded 2025 revenue guidance. Click here to find out why ...

Global chemical company Evonik has announced that VECOLLAN®, its recombinant, non-animal-derived collagen-like protein ...

Amphastar Pharmaceuticals ( ($AMPH) ) just unveiled an update. On September 15, 2025, Amphastar Pharmaceuticals entered into a contract research ...

ANN ARBOR, Mich., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, is happy to announce the ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it is actively pursuing the acquisition of an additional ...

Russian pharmaceutical company Medsintez and VNVC Vaccine and Biopharmaceutical Manufacturing Plant have signed a ...